Total Payments
$315.81
2024 Payments
$25.95
Companies
1
Transactions
12
Medicare Patients
3,422
Medicare Billing
$164,557
Payment Breakdown by Category
Food & Beverage$315.81 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $315.81 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $315.81 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.95 | 1 | AstraZeneca Pharmaceuticals LP ($25.95) |
| 2023 | $74.10 | 3 | AstraZeneca Pharmaceuticals LP ($74.10) |
| 2022 | $59.36 | 3 | AstraZeneca Pharmaceuticals LP ($59.36) |
| 2020 | $11.36 | 1 | AstraZeneca Pharmaceuticals LP ($11.36) |
| 2019 | $145.04 | 4 | AstraZeneca Pharmaceuticals LP ($145.04) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Respiratory | ||||||
| 10/30/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Respiratory | ||||||
| 08/07/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Respiratory | ||||||
| 01/10/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Respiratory | ||||||
| 09/15/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Respiratory | ||||||
| 06/03/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Respiratory | ||||||
| 03/02/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Respiratory | ||||||
| 01/23/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Respiratory | ||||||
| 08/29/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $101.20 | General |
| Category: Respiratory | ||||||
| 08/28/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Respiratory | ||||||
| 07/30/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Respiratory | ||||||
| 04/02/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,181 | 1,337 | $205,458 | $39,862 |
| 2022 | 15 | 1,113 | 1,301 | $222,595 | $41,747 |
| 2021 | 16 | 751 | 891 | $214,068 | $39,036 |
| 2020 | 11 | 377 | 586 | $227,892 | $43,912 |
Total Patients
3,422
Total Services
4,115
Medicare Billing
$164,557
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 113 | 153 | $62,095 | $11,169 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 124 | 152 | $43,722 | $6,505 | 14.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 46 | $18,351 | $4,706 | 25.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 69 | $16,771 | $4,207 | 25.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 36 | 45 | $12,938 | $2,150 | 16.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 14 | $7,460 | $1,976 | 26.5% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 94 | 99 | $6,699 | $1,675 | 25.0% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 262 | 277 | $6,911 | $1,672 | 24.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 240 | 251 | $6,774 | $1,635 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $7,881 | $1,625 | 20.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 176 | 177 | $6,451 | $1,570 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 23 | 23 | $8,169 | $871.85 | 10.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Facility | 2023 | 14 | 16 | $1,236 | $100.66 | 8.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 156 | 232 | $67,939 | $10,845 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 89 | 115 | $47,697 | $8,096 | 17.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 33 | $13,572 | $3,673 | 27.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 48 | 57 | $16,652 | $2,899 | 17.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 25 | 26 | $8,024 | $2,147 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 33 | 33 | $11,882 | $2,082 | 17.5% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 103 | 117 | $8,135 | $2,074 | 25.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 34 | $7,494 | $2,002 | 26.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 201 | 219 | $6,075 | $1,533 | 25.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 193 | 210 | $5,412 | $1,357 | 25.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 133 | 133 | $4,982 | $1,273 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $7,475 | $1,245 | 16.7% |
About Dr. Michael Agustin, M.D
Dr. Michael Agustin, M.D is a Critical Care Medicine healthcare provider based in Dededo, Guam. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1215248356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Agustin, M.D has received a total of $315.81 in payments from pharmaceutical and medical device companies, with $25.95 received in 2024. These payments were reported across 12 transactions from 1 company. The most common payment nature is "Food and Beverage" ($315.81).
As a Medicare-enrolled provider, Agustin has provided services to 3,422 Medicare beneficiaries, totaling 4,115 services with total Medicare billing of $164,557. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Internal Medicine, Critical Care Medicine
- Location Dededo, GU
- Active Since 06/23/2010
- Last Updated 05/23/2019
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1215248356
Products in Payments
- FASENRA (Drug) $156.40
- FASENRA (Biological) $82.98
- TEZSPIRE (Biological) $76.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.